HTLV-1 associated myelopathy in Canada.

We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for...

Full description

Bibliographic Details
Main Authors: Power, C, Weinshenker, BG, Dekaban, G, Ebers, G, Francis, G, Rice, G
Format: Journal article
Language:English
Published: 1989
_version_ 1826289807377039360
author Power, C
Weinshenker, BG
Dekaban, G
Ebers, G
Francis, G
Rice, G
author_facet Power, C
Weinshenker, BG
Dekaban, G
Ebers, G
Francis, G
Rice, G
author_sort Power, C
collection OXFORD
description We report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for HTLV-1 infection. Tropical spastic paraparesis should be considered in all patients with myelopathy, even those without standard serological markers of HTLV-1 infection. The pathogenesis of this condition and the serological and molecular biological means by which this diagnosis can be made are reviewed.
first_indexed 2024-03-07T02:34:32Z
format Journal article
id oxford-uuid:a858d74b-0306-43f5-9ee6-cec9170649b1
institution University of Oxford
language English
last_indexed 2024-03-07T02:34:32Z
publishDate 1989
record_format dspace
spelling oxford-uuid:a858d74b-0306-43f5-9ee6-cec9170649b12022-03-27T03:00:53ZHTLV-1 associated myelopathy in Canada.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a858d74b-0306-43f5-9ee6-cec9170649b1EnglishSymplectic Elements at Oxford1989Power, CWeinshenker, BGDekaban, GEbers, GFrancis, GRice, GWe report the clinical and laboratory findings of six Canadian patients with progressive myelopathy associated with HTLV-1 infection. The diagnosis was suspected on clinical grounds and supported by serological studies and positive gene amplification. Only five had emigrated from an area endemic for HTLV-1 infection. Tropical spastic paraparesis should be considered in all patients with myelopathy, even those without standard serological markers of HTLV-1 infection. The pathogenesis of this condition and the serological and molecular biological means by which this diagnosis can be made are reviewed.
spellingShingle Power, C
Weinshenker, BG
Dekaban, G
Ebers, G
Francis, G
Rice, G
HTLV-1 associated myelopathy in Canada.
title HTLV-1 associated myelopathy in Canada.
title_full HTLV-1 associated myelopathy in Canada.
title_fullStr HTLV-1 associated myelopathy in Canada.
title_full_unstemmed HTLV-1 associated myelopathy in Canada.
title_short HTLV-1 associated myelopathy in Canada.
title_sort htlv 1 associated myelopathy in canada
work_keys_str_mv AT powerc htlv1associatedmyelopathyincanada
AT weinshenkerbg htlv1associatedmyelopathyincanada
AT dekabang htlv1associatedmyelopathyincanada
AT ebersg htlv1associatedmyelopathyincanada
AT francisg htlv1associatedmyelopathyincanada
AT riceg htlv1associatedmyelopathyincanada